SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenues	$ 7,009	$ 6,205
Cost of Revenues:
Material and Labor	4,698	3,807
Other cost of revenues	805	591
Total Cost of Revenues	5,503	4,398
Research and development (R&D)
Share based compensation	10,138	4,490
Total Research and development	13,634	7,981
Selling and marketing (S&M)
Total Selling and marketing	6,069	3,865
General and administrative (G&A)
Total General and administrative	15,306	11,104
Financial Income, net;	1,557	1,292
Tax Expenses	59	65
NET LOSS	(32,005)	(19,916)
Research and Development Expense [Member]
Research and development (R&D)
Payroll and Benefits	2,858	1,916
Share based compensation	2,412	649
Clinical trials	3,815	3,300
Other R&D	4,549	2,116
Selling and Marketing Expense [Member]
Research and development (R&D)
Payroll and Benefits	3,769	2,508
Share based compensation	1,025	416
Selling and marketing (S&M)
Other S&M	1,275	941
General and Administrative Expense [Member]
Research and development (R&D)
Payroll and Benefits	4,221	3,344
Share based compensation	6,445	3,332
General and administrative (G&A)
Other G&A	$ 4,640	$ 4,428